BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6092136)

  • 41. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K; Bektaş M; Gökçe S; Nurten R
    Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coliphage-induced ADP-ribosylation of Escherichia coli RNA polymerase.
    Goff CG
    Methods Enzymol; 1984; 106():418-29. PubMed ID: 6092834
    [No Abstract]   [Full Text] [Related]  

  • 43. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G; Abraham AK; Vedeler A
    FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein ADP-ribosylation in rat liver cytosol.
    Skala H; Vibert M; Weber A; Kahn A; Dreyfus JC
    Biochem Int; 1983 Dec; 7(6):747-54. PubMed ID: 6091660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proceedings: Elongation factor 2: amino acid sequence at the site of ADP-ribosylation.
    Maxwell ES; Robinson EA; Henriksen O
    J Biochem; 1975 Jan; 77(1?):9p-b. PubMed ID: 1137991
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence of a yeast proteinase specific for elongation factor 2.
    Servillo L; Quagliuolo L; Balestrieri C; Giovane A
    FEBS Lett; 1988 Dec; 241(1-2):257-60. PubMed ID: 3058513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of biotinylated NAD to label and purify ADP-ribosylated proteins.
    Zhang J
    Methods Enzymol; 1997; 280():255-65. PubMed ID: 9211321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isoproterenol-induced ADP-ribosylation of a single plasma membrane protein of cultured differentiated RL-PR-C hepatocytes.
    Reilly TM; Beckner S; McHugh EM; Blecher M
    Biochem Biophys Res Commun; 1981 Feb; 98(4):1115-20. PubMed ID: 6261757
    [No Abstract]   [Full Text] [Related]  

  • 49. ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products.
    Van Ness BG; Howard JB; Bodley JW
    J Biol Chem; 1980 Nov; 255(22):10717-20. PubMed ID: 7000782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of proteins by mono(ADP-ribosylation) in vivo.
    Payne DM; Jacobson EL; Moss J; Jacobson MK
    Biochemistry; 1985 Dec; 24(26):7540-9. PubMed ID: 4092023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O; Nilsson L
    J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonenzymic ADP-ribosylation of specific mitochondrial polypeptides.
    Hilz H; Koch R; Fanick W; Klapproth K; Adamietz P
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):3929-33. PubMed ID: 6588374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tubulin adenosine diphosphate ribosylation is catalyzed by cholera toxin.
    Hawkins DJ; Browning ET
    Biochemistry; 1982 Aug; 21(18):4474-9. PubMed ID: 7126551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B; Rattan SI; Clark BF
    J Biochem Biophys Methods; 1989 Oct; 19(4):319-25. PubMed ID: 2693515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O; Ozdemirli M; Nurten R; Bermek E
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK; Ovchinnikov LP
    FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histone-dependent ADP-ribosylation of low molecular nucleotide by poly(ADP-ribose) polymerase.
    Tanaka Y; Matsunami N; Itaya A; Yoshihara K
    J Biochem; 1981 Oct; 90(4):1131-9. PubMed ID: 6273393
    [No Abstract]   [Full Text] [Related]  

  • 58. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADP-ribosylation.
    Ueda K; Hayaishi O
    Annu Rev Biochem; 1985; 54():73-100. PubMed ID: 3927821
    [No Abstract]   [Full Text] [Related]  

  • 60. Increased phosphorylation of elongation factor 2 in Alzheimer's disease.
    Johnson G; Gotlib J; Haroutunian V; Bierer L; Nairn AC; Merril C; Wallace W
    Brain Res Mol Brain Res; 1992 Oct; 15(3-4):319-26. PubMed ID: 1331687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.